134 related articles for article (PubMed ID: 17917550)
1. Which antidepressants have demonstrated superior efficacy? A review of the evidence.
Montgomery SA; Baldwin DS; Blier P; Fineberg NA; Kasper S; Lader M; Lam RW; Lépine JP; Möller HJ; Nutt DJ; Rouillon F; Schatzberg AF; Thase ME
Int Clin Psychopharmacol; 2007 Nov; 22(6):323-9. PubMed ID: 17917550
[TBL] [Abstract][Full Text] [Related]
2. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].
Gaillard R
Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726
[TBL] [Abstract][Full Text] [Related]
3. [Severe forms of depression: the efficacy of escitalopram].
Spadone C
Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
[TBL] [Abstract][Full Text] [Related]
4. Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.
Eckert L; Falissard B
Curr Med Res Opin; 2006 Nov; 22(11):2313-21. PubMed ID: 17076991
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine: new preparation. Just another antidepressant.
Prescrire Int; 1998 Aug; 7(36):112-4. PubMed ID: 10342950
[TBL] [Abstract][Full Text] [Related]
6. Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
Montgomery SA; Möller HJ
Int Clin Psychopharmacol; 2009 May; 24(3):111-8. PubMed ID: 19357527
[TBL] [Abstract][Full Text] [Related]
7. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
8. Long-term effectiveness of cognitive therapy in major depressive disorder.
Hensley PL; Nadiga D; Uhlenhuth EH
Depress Anxiety; 2004; 20(1):1-7. PubMed ID: 15368590
[TBL] [Abstract][Full Text] [Related]
9. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting.
Bukh JD; Jørgensen MB; Dam H; Plenge P
Nord J Psychiatry; 2009; 63(4):347-51. PubMed ID: 19347769
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Müller N; Schennach R; Riedel M; Möller HJ
Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
[TBL] [Abstract][Full Text] [Related]
12. An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder.
Ballesteros J; Callado LF; Gutiérrez M
J Clin Psychopharmacol; 2007 Apr; 27(2):219-21. PubMed ID: 17414254
[No Abstract] [Full Text] [Related]
13. Intravenous antidepressants: a review.
Moukaddam NJ; Hirschfeld RM
Depress Anxiety; 2004; 19(1):1-9. PubMed ID: 14978779
[TBL] [Abstract][Full Text] [Related]
14. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis.
Furukawa TA; Salanti G; Atkinson LZ; Leucht S; Ruhe HG; Turner EH; Chaimani A; Ogawa Y; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Suganuma A; Watanabe N; Stockton S; Geddes JR; Cipriani A
BMJ Open; 2016 Jul; 6(7):e010919. PubMed ID: 27401359
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
[TBL] [Abstract][Full Text] [Related]
17. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
18. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
[TBL] [Abstract][Full Text] [Related]
19. [The comparative studies of therapeutic results in patients with psychotic refractory depression treated with selected antidepressants and unilateral ECT].
Hese RT; Gruszczyński W; Szwed A; Kielc M; Zalitacz M
Psychiatr Pol; 2002; 36(6 Suppl):81-4. PubMed ID: 12647425
[TBL] [Abstract][Full Text] [Related]
20. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
Ghaemi SN
Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
